Viridian Therapeutics Insider Trades

VRDN

Track insider trading activity from Viridian Therapeutics executives and directors. See which insiders are buying and selling VRDN stock.

Trades Last 12 Months

VRDN Price

All Insider Trades for Viridian Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $617k 32,341 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 32,341 shares
$18.48
$19.08
Holding Value $617k 32,341 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 32,341 shares
$18.48
$19.08
Gheuens Sarah Director
Holding Value $617k 32,341 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 32,341 shares
$18.48
$19.08
Holding Value $617k 32,341 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 32,341 shares
$18.48
$19.08
Morris Arlene Director
Holding Value $617k 32,341 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 32,341 shares
$18.48
$19.08
Kiselak Tomas Director
Holding Value $617k 32,341 shares
Last Trade
Jul 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 32,341 shares
$18.48
$19.08
Holding Value $97.1M 5,090,928 shares
Last Trade
May 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20M 1,176,470 shares
$17.00
$19.08
Harmon Seth Chief Financial Officer
Holding Value $149k 7,790 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.3k 2,091 shares
$29.32
$19.08
Beetham Thomas W. Chief Operating Officer
Holding Value $313k 16,409 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$276k 9,409 shares
$29.32
$19.08
Tousignant Jennifer Chief Legal Officer
Holding Value $65.7k 3,445 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$50.5k 1,724 shares
$29.32
$19.08
Mahoney Stephen F. President And CEO
Holding Value $778k 40,757 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$538k 18,357 shares
$29.32
$19.08
Tripuraneni Radhika Chief Medical Officer
Holding Value $1.83M 95,800 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.48M 114,950 shares
$30.25
$19.08
Holding Value $401k 21,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$304k 21,000 shares
$14.47
$19.08
Holding Value $401k 21,000 shares
Last Trade
Jun 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$259k 21,000 shares
$12.31
$19.08
Ciulla Thomas Chief Medical Officer
Holding Value $954k 50,000 shares
Last Trade
Feb 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$935k 50,000 shares
$18.70
$19.08
Meisner Lara Chief Legal Officer
Holding Value $572k 29,998 shares
Last Trade
Jun 16, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$732 27 shares
$27.12
$19.08
Myers Scott Dunseth Chief Executive Officer
Holding Value $4.95M 259,500 shares
Last Trade
Apr 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$101k 4,000 shares
$25.37
$19.08
Katz Barrett Chief Medical Officer
Holding Value $2.06M 108,000 shares
Last Trade
Feb 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.69M 108,000 shares
$34.20
$19.08
Humer Kristian CFO And CBO
Holding Value $2.06M 108,000 shares
Last Trade
Feb 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.69M 108,000 shares
$34.20
$19.08
Holding Value $1.03M 54,000 shares
Last Trade
Feb 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.85M 54,000 shares
$34.20
$19.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up